新修订的药品管理法第八章第七十一条对药品不良反应监测管理工作作如下规定: “国家实行药品不良反应报告制度。药品生产企业、药品经营企业和医疗机构必须经常考察本单位所生产、经营、使用的药品质量、疗效和反应。发现可能与用药有关的严重不良反应,必须及时向当地省、自治区、直辖市人民政府药品监督管理部门和卫生行政部门报告。具体办法由国务院药品监督管理部门会同 Article 71 of the newly revised Chapter VIII of the Drug Administration Law makes the following provisions on the monitoring and management of adverse drug reactions as follows: “The State implements the reporting system of adverse drug reactions.” Drug manufacturing enterprises, pharmaceutical enterprises and medical institutions must regularly inspect the units The quality, efficacy and response of the drugs produced, operated and used shall be reported to the drug regulatory authorities and health administrative departments of the people’s governments of the local provinces, autonomous regions and municipalities directly under the Central Government in a timely manner if any serious adverse drug reactions may be found. Management together